Zealand Pharma A/S
ZLDPF
$54.00
$0.480.90%
OTC PK
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -28.02% | -42.07% | -61.31% | 2,827.35% | -41.94% |
| Total Depreciation and Amortization | 117.71% | 41.97% | 24.03% | -3.18% | -26.81% |
| Total Amortization of Deferred Charges | -- | 34.81% | -- | -- | -- |
| Total Other Non-Cash Items | -187.08% | -3,295.02% | 762.42% | 2,286.30% | 232.38% |
| Change in Net Operating Assets | -68.39% | 342.22% | -978.81% | -1,192.39% | -3,743.47% |
| Cash from Operations | -46.01% | -530.18% | -59.73% | 3,982.45% | -116.99% |
| Capital Expenditure | -81.42% | -1,461.81% | -1,438.54% | -32.93% | -64.64% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -120.57% | -318.10% | 85.09% | -6,424.97% | 139.53% |
| Cash from Investing | -122.75% | -329.92% | 85.03% | -5,354.78% | 139.01% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -125.00% | -30.44% | -29.57% | -15.92% | -3.73% |
| Issuance of Common Stock | -66.67% | 20,418.52% | -62.82% | -99.62% | -99.80% |
| Repurchase of Common Stock | -- | -- | 72.39% | -310.23% | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -770.59% | 351.95% | 69.43% | -104.84% | -100.05% |
| Foreign Exchange rate Adjustments | 2,567.23% | 184.83% | 5,865.50% | -18,757.00% | -180.24% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1,684.89% | -35,181.24% | 79.66% | 5.18% | -78.29% |